Home NDC 76961-101 Rolvedon
Product NDC 76961-101
11-digit product format 769610101
Labeler code 76961
Product ID 76961-101_9209fc63-aee3-43dc-9bc6-16c5ed73d858
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name eflapegrastim-xnst
Dosage form INJECTION, SOLUTION
Route SUBCUTANEOUS
Labeler Spectrum Pharmaceuticals, Inc.
Application BLA761148
Marketing category BLA
Marketing start 2022-10-18
Marketing end 2027-08-31
Substance EFLAPEGRASTIM
Active strength 13.2 mg/.6mL
Pharmacologic classes Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]
NDC exclude flag No
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Rolvedon Active Ingredients# Ingredient, Strength table Ingredient Strength EFLAPEGRASTIM 13.2 mg/.6mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination UT99UG9QJX Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2612541 Internal RxNorm lookup 2612547 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 76961-101-01 Rolvedon 0.6 mL in 1 SYRINGE, GLASS INJECTION, SOLUTION 0.6 6
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 76961-101 ROLVEDON (EFLAPEGRASTIM-XNST) INJECTION, SOLUTION [SPECTRUM PHARMACEUTICALS, INC.] 4 Current NDC, Legacy NDC, 1 package rows 20240316_6e436115-62e7-4729-aeb0-ff78ea685206.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761148 Rolvedon eflapegrastim-xnst 351(a) Rx 2026-07-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 76961-101-01 76961010101 .6 mL in 1 SYRINGE, GLASS (76961-101-01) 2022-10-18 2027-08-31 No No Current